Prodigiosin: a promising biomolecule with many potential biomedical applications. Issue 6 (1st June 2022)

• Record Type: Journal Article
• Authors: Islan, German A.; Rodenak-Kladniew, Boris; Noacco, Nehuen; Duran, Nelson; Castro, Guillermo R.
• Is Part Of: Bioengineered. Volume 13:Issue 6(2022)
• Page Start: 14227
• Page End: 14258
• Publication Date: 2022-06-01
• Subjects: Prodigiosin -- serratia marcescens -- prodigiosin production -- prodigiosin biological activities -- anticancer -- antimicrobial -- antifungal; Biomedical engineering -- Periodicals; Biotechnology -- Periodicals; Microbiology -- Periodicals; 660.6
• DOI: 10.1080/21655979.2022.2084498
• Languages: English
• ISSNs: 2165-5987

Abstract

ABSTRACT: Pigments are among the most fascinating molecules found in nature and used by human civilizations since the prehistoric ages. Although most of the bio-dyes reported in the literature were discovered around the eighties, the necessity to explore novel compounds for new biological applications has made them resurface as potential alternatives. Prodigiosin (PG) is an alkaloid red bio-dye produced by diverse microorganisms and composed of a linear tripyrrole chemical structure. PG emerges as a really interesting tool since it shows a wide spectrum of biological activities, such as antibacterial, antifungal, algicidal, anti-Chagas, anti-amoebic, antimalarial, anticancer, antiparasitic, antiviral, and/or immunosuppressive. However, PG vehiculation into different delivery systems has been proposed since possesses low bioavailability because of its high hydrophobic character (XLogP3-AA = 4.5). In the present review, the general aspects of the PG correlated with synthesis, production process, and biological activities are reported. Besides, some of the most relevant PG delivery systems described in the literature, as well as novel unexplored applications to potentiate its biological activity in biomedical applications, are proposed. GRAPHICAL ABSTRACT: uf0001